Reuters logo
BRIEF-Tenax hires Ladenburg Thalmann to review strategic options
April 5, 2017 / 9:54 PM / 8 months ago

BRIEF-Tenax hires Ladenburg Thalmann to review strategic options

April 5 (Reuters) - Tenax Therapeutics Inc

* Tenax Therapeutics announces review of strategic alternatives and business update

* Tenax Therapeutics - Ladenburg Thalmann engaged to assist in process

* Tenax Therapeutics - John Kelley resigns as CEO; Michael Jebsen, president and CFO, appointed as interim CEO

* Tenax Therapeutics - company continues to evaluate results of LEVO-CTS clinical trial

* Tenax - strategic review process includes merger, business combination, strategic investment into co, purchase, license or other acquisition of assets Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below